Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00249587

Medication Adherence Therapy for Opioid Abusing Pain Patients

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Chronic Disease Pain Prescription Opioid Abuse

Interventions Methadone

Updated 5 times since 2017 Last updated: Jan 9, 2017 Started: Sep 30, 2000 Primary completion: Sep 30, 2005 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00249587, this PHASE1/PHASE2 trial focuses on Chronic Disease and Pain and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 5 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States